SCHEMBL8643294

SCHEMBL8643294

CC(=O)O[C@@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 1.00
CYP3A4 P08684 7/20 1.00
KMT2A Q03164 6/20 1.00
MEN1 O00255 5/20 1.00
ALOX15 P16050 3/20 1.00
MAPK1 P28482 3/20 1.00
RECQL P46063 2/20 1.00
BRCA1 P38398 1/20 1.00
MAPT P10636 7/20 0.79
ESR1 P03372 7/20 0.79
TP53 P04637 4/20 0.79
SMN1; SMN2 Q16637 4/20 0.79
HIF1A Q16665 2/20 0.75
PGR P06401 3/20 0.74
AR P10275 3/20 0.74
ADORA3 P0DMS8 2/20 0.74
PTGS1 P23219 2/20 0.74
PDE3A Q14432 2/20 0.74
POLB P06746 1/20 0.74
CHRM1 P11229 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13177178 1.00 LMNA (1.00) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL12072310 1.00 LMNA (1.00) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL7260222 1.00 LMNA (1.00) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL8991456 1.00 LMNA (1.00) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL147037 1.00 LMNA (1.00) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL12186917 1.00 LMNA (1.00) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL8495807 0.92 LMNA (0.84) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL24103244 0.91 LMNA (0.84) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL9273487 0.90 LMNA (0.82) LMNACYP3A4KMT2AMEN1ALOX15
SCHEMBL15292940 0.90 LMNA (0.82) LMNACYP3A4KMT2AMEN1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4021458-A Process for the preparation of 3-hemisulfate-17α-hydroxy steroids SCHERING AKTIENGESELLSCHAFT (DT) 1977-05-03 US claimed
WO-2023223235-A1 LIPOSOMAL PREPARATION WITH ENCAPSULATED HORMONES, METHOD OF PRODUCTION AND USE THEREOF PURNA PHARMACEUTICALS NV (BE) 2023-11-23 WO disclosed
CN-109414553-A Method and apparatus for controlling drug evaporation 普林斯顿大学理事会 2019-03-01 CN disclosed
CN-103079587-B Glucagon superfamily peptides exhibiting nuclear hormone receptor activity INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) 2016-05-11 CN disclosed
CN-1083259-C Transdermal matrix system LHD LAB HYGIENE DIETETIQUE (FR) 2002-04-24 CN disclosed
EP-0722455-B1 PROCESS FOR PRODUCING SULFURIC ACID SEMI-ESTERS SCHERING AG (DE) 1998-08-19 EP disclosed
WO-1998004578-A1 METHOD OF PRODUCING 3-SULFANATO-OXY-ESTRA-1,3,5(10)-TRIEN DERIVATES (I) SCHERING AG (DE) 1998-02-05 WO disclosed
US-5703261-A Process for the production of sulfuric acid semi-esters SCHERING AKTIENGESELLSCHAFT (DE) 1997-12-30 US disclosed
US-4021458-A Process for the preparation of 3-hemisulfate-17α-hydroxy steroids SCHERING AKTIENGESELLSCHAFT (DT) 1977-05-03 US disclosed